Exacerbation of previously undetected ulcerative colitis in a patient undergoing nivolumab for metastatic melanoma: A case report
Mild ulcerative colitis can be unmasked and exacerbated by immune checkpoint inhibitors such as nivolumab, emphasizing the importance of early evaluation for inflammatory bowel disease in patients with persistent diarrhea.
Authors
- Young‐Eun Joo (ORCID: https://orcid.org/0000-0003-0422-2439)
- Je-Seong Kim
- Joo-Yeon Koo (ORCID: https://orcid.org/0000-0003-0551-5954)
- Chan-Muk Im
- Young-Eun Seo
- Chae-June Lim
- Hyung-Hoon Oh
Institutions
- Chonnam National University Hwasun Hospital (KR)
- S.P.E.C.I.E.S. (US)
- La Salle University (US)
Publication Details
- Journal
- Medicine
- Published
- 2025-09-26
- DOI
- https://doi.org/10.1097/md.0000000000044833
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00